Details of the Drug
General Information of Drug (ID: DM7KD5Y)
Drug Name |
Azithromycin-N-benzyltriazolylhexahydroxamic Acid
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | Azithromycin-N-benzyltriazolylhexahydroxamic Acid; CHEMBL446811; SCHEMBL14328156; CHEMBL3735805; BDBM27177; triazole-linked azithromycin-based compound, 16a | |||||||||||||||||||
Indication |
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 4 | Molecular Weight (mw) | 1021.3 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 4.7 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 16 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 7 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 18 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References